NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $300,000 | -66.6% | 6,842 | -28.9% | 0.02% | -45.5% |
| Q4 2021 | $898,000 | +87.9% | 9,618 | +124.4% | 0.03% | +32.0% |
| Q3 2021 | $478,000 | +107.8% | 4,287 | +89.0% | 0.02% | +92.3% |
| Q1 2021 | $230,000 | -29.9% | 2,268 | -31.3% | 0.01% | -51.9% |
| Q4 2020 | $328,000 | -51.0% | 3,300 | -85.3% | 0.03% | -66.7% |
| Q1 2020 | $669,000 | -5.0% | 22,400 | +7.2% | 0.08% | +39.7% |
| Q4 2019 | $704,000 | +1.7% | 20,900 | -0.9% | 0.06% | +38.1% |
| Q3 2019 | $692,000 | – | 21,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |